retatrutide weight loss results clinical trials Eli Lilly's shows promising in phase 3 trial Retatrutide just posted Phase 3

Most of this research is still in early stages but is showing great promise for new off label uses in the world of psychiatry

Constipation is common with weight loss and should be managed proactively

Efforts to tighten regulations have repeatedly failed in the legislature, leaving critics warning that these are not haircuts theyre medical procedures. Prescription Drug Affordability Board (PDAB) activity States in dark red have passed legislation to create a PDAB

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications prescribed in the UK for managing type 2 diabetes and, in specific formulations, for weight management

To help navigate this shifting environment, pharma companies should consider the following imperatives: GLP1s are expanding far beyond diabetes and obesity

Through Q1 2024, theyre still by far the most-searched drugs by RxSS membersand no doubt among the broader population, too